As a sponsor of the event, The Clinician team will be showcasing their healthcare solutions on the exhibition floor at booth F18 and will be hosting a dedi...
The Phase 3 ELEVATE study demonstrated atogepant is effective and well-tolerated for the preventive treatment of episodic migraine in people who previous...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers studying cancer ...
Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell th...
The format will feature presentations by members of Thermo Fisher Scientific’s senior management team and conclude with a Q&A session. You can a...
The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to th...
With many of the largest CDMOs now running at capacity, drug sponsors will need to focus on mitigating risk and building resiliency when using smaller or m...
This year's Healthcare Revolution is about the failings of the American Dream with rising and unsustainable healthcare costs, and how employers can navigat...
Registration is open for women in the life sciences industry to join the fourth MedExecWomen Annual Conference, Growing Your Business, Yourself,...
© 2025 Biopharma Boardroom. All Rights Reserved.
